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Background
Cervical cancer is highly prevalent in developing coun-
tries. In Uganda, overall incidence rate is estimated at 44
per 100,000 women and 60 per 100,000 among HIV
infected women. However, only 30% of women have ever
been screened for cervical cancer and linkage to treat-
ment after diagnosis is suboptimal. For HIV infected
women, who are at highest risk of cervical cancer, the
HIV care delivery system provides an opportunity for
cervical cancer services. In this paper we share the Mild-
may Uganda (MUg) experiences in integrating cervical
cancer services into HIV care.
Program implementation
The MUg clinic is a centre of excellence that has been
delivering HIV clinical care since 1998 and has supported
over 60,000 clients to date. In 2008, MUg started screen-
ing the HIV infected women for pre-cancerous lesions
using PAP smears, and eventually introduced visual
inspection with acetic acid (VIA) in 2011. Screening is
conducted by trained nurses through an opt-out model
and an onsite see-and-treat (same-day treatment) with
cryotherapy for women with growing lesions.
Program outcomes
The introduction of the opt-out model and screening by
nurses has led to drastic increases in the number of
women screened and treated for cervical cancer since
2012. In 2011, a total of 730 women were screened, while
in 2012, 3,857 women were screened. In 2013, 2,580
women were screened. Overall, refusal of screening was
less than 5%. The number of women observed with
advanced cancerous lesions has drastically reduced since
introduction of the opt-out screening. For example, in
the first half of 2012, of the 96 women who were VIA
positive, 56% had advanced lesions compared to 41% in
the latter half of 2012, 32% in the first half of 2013, and
15% in the latter half of 2013.
Lessons learnt
Integration of cervical cancer services in HIV care pro-
grams is possible, cost-effective and makes the screening
service more accessible by a vulnerable population. Using
an opt-out approach and same-day treatment increases
access to cervical cancer screening and reduces the pro-
portion of women presenting with advanced lesions.
Trained nurses ably deliver cervical cancer services.
See-and-treat approach reduces cases who fail to access
treatment due to gaps in health care linkages.
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